2001
DOI: 10.1007/bf03033209
|View full text |Cite
|
Sign up to set email alerts
|

Acute exposure to organochlorine pesticides does not affect striatal dopamine in mice

Abstract: The purpose of this study was to evaluate the possible association between the risk of developing Parkinson's disease (PD) and exposure to organochlorine pesticides in the mouse model. Animals were treated with a single subcutaneous injection of either dieldrin (40 and 80 mg/kg) or 2,4-dichlorophenoxyacetic acid (100 and 200 mg/kg, 2,4-D) and levels of dopamine (DA) and DA metabolites were measured in the striatum at the 7-day time point. Dieldrin exposure did not affect the striatal concentrations of DA, 3,4-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 35 publications
0
4
0
Order By: Relevance
“…Similarly, mice injected with a single subcutaneous injection of dieldrin (40 and 80 mg/kg) after 7 days showed no significant changes in levels of striatal dopamine (DA) and DOPAC (Thiffault et al, 2001). However, in some studies, dieldrin has also been shown to deplete DA production in mammals in vivo .…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, mice injected with a single subcutaneous injection of dieldrin (40 and 80 mg/kg) after 7 days showed no significant changes in levels of striatal dopamine (DA) and DOPAC (Thiffault et al, 2001). However, in some studies, dieldrin has also been shown to deplete DA production in mammals in vivo .…”
Section: Discussionmentioning
confidence: 99%
“…It remains to be determined if this potentially toxic event is a direct result of dieldrin interaction with the transporter or related to mitochondrial energy failure. While single high dose administration of dieldrin in mice fails to induce any significant changes in striatal DA and metabolite concentrations [130], chronic dosing paradigms show depletion of brain DA levels in a variety of animal models [125,[131][132][133]. Furthermore, changes in dopamine transporter and VMAT2 levels [134,135], decreased DA metabolite levels, and increased cysteinyl-catechol adducts in the striatum [125] suggest alterations in the uptake, storage, and metabolism of DA in the nigrostriatal pathway.…”
Section: Dieldrinmentioning
confidence: 99%
“…Although dieldrin has often been administered directly to mice (Hatcher et al, 2007;Richardson et al, 2006;Thiffault et al, 2001) these studies have used varying treatment parameters, meaning that often conflicting results must be evaluated carefully. The ban on dieldrin also means that there is less interest in fully establishing its status as a factor in neurodegeneration, and it is unlikely to see further development as a model of PD.…”
Section: Development Of Animal Modelsmentioning
confidence: 99%